Precision Medicine for aTTP: Expert Answers to Your Questions
CCO Oncology Podcast
English - February 01, 2022 20:05 - 19 minutes - 18.4 MBCourses Education Health & Fitness Medicine essential thrombocythemia myelofibrosis oncology cme skin cancer acute myeloid leukemia kidney cancer melanoma gastrointestinal cancer prostate can Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
In this episode, Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshal Mazepa, MD, answer questions from an audience of healthcare professionals on topics related to the management of acquired thrombotic thrombocytopenic purpura (aTTP), including:
Rationale of the CAPLAVIE regimen of caplacizumab with corticosteroids and rituximab in aTTP in the acute phaseData for caplacizumab in pediatric patients with aTTPInitiating rituximab after completion of plasma exchangeInternational Society on Thrombosis and Haemostasis guideline recommendations against using aspirinTriggers of aTTP episodes aside from infectionEffect of COVID-19 vaccines and COVID-19 infections on aTTP onset or relapsePresenters:
Ara Metjian, MD
Associate Professor
Division of Hematology
Department of Medicine
University of Colorado, Anschutz Medical Campus
Aurora, Colorado
Paul Coppo, MD, PhD
Professor of Hematology
Hematology Department, AP-HP
Sorbonne University
Paris, France
Marshall Mazepa, MD
Assistant Professor of Medicine
Division of Hematology, Oncology, and Transplantation
University of Minnesota
Minneapolis, Minnesota
Link to the complete program, including downloadable slidesets, an expert commentary, an on-demand webcast, and healthcare professional resource guide:
https://bit.ly/3J1fcad